NIVABUPA Niva Bupa Health Insurance Company Q3 FY26 results (Oct–Dec 2025) and concall
Niva Bupa Health delivered a strong Q3 FY26, marked by accelerated growth in new business and an expanding retail market share. Profitability saw a significant YoY improvement, and the combined ratio strengthened due to better expense management, which offset a slight increase in the loss ratio. Management highlighted positive tailwinds from GST changes, strong traction for its new 'Reassure 3.0' product, and ongoing industry-wide initiatives to manage claims costs through standardization, positioning the company for sustained performance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 28.1%, net profit down 776.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 +19% | 1,611 +28% |
| EBITDA | -66 | -24 | 251 | 98 | -53 +20% | -94 −292% |
| Net profit | 13 | 13 | 206 | 71 | -35 −369% | -88 −777% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
